COPENHAGEN, Sept 13 (Reuters) - Danish drugmaker Novo Nordisk said new data showed people with type 2 diabetes experienced improvements in controlling blood sugar levels when using its diabetes drug ...

The logo of Teva Pharmaceutical Industries is displayed at the company headquarters in Tel Aviv (Reuters) -Teva Pharmaceuticals said on Monday it had launched a generic version of Novo Nordisk's ...

Share on Pinterest A new generic of the GLP-1 drug Victoza, which is similar to popular medications like Ozempic, Wegovy, Mounjaro, and Zepbound, is now available in the United States.

Liraglutide is an injectable prescription medicine used: along with diet and exercise to lower blood sugar (glucose) in adults and children who are 10 years of age and older with type 2 diabetes ...

LONDON (Reuters) - Novo Nordisk's big new drug hope Victoza has been recommended for limited use on Britain's state-run health service as a treatment for diabetes, the Danish drugmaker said on Monday.

Generic Victoza is indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older, with Type 2 diabetes mellitus. Lupin is releasing ...

(Reuters) -Teva Pharmaceuticals said on Monday it had launched a generic version of Novo Nordisk's Victoza to treat patients with type 2 diabetes, making it the first generic GLP-1 drug in the United ...